CARPL.ai secured $10M in Series A funding to expand its global radiology AI marketplace.
Key Details
- 1CARPL.ai raised $10 million in Series A, led by International Finance Corp. (IFC).
- 2The platform offers over 300 radiology AI applications from 100+ partners.
- 3CARPL is already used by 4 of the world’s 5 largest radiology groups and various governments worldwide.
- 4The company aims to grow its partner network and expand into North America, and plans to move beyond imaging AI in the future.
- 5CARPL has dual headquarters in Delhi and San Francisco, leveraging deep tech talent in India.
Why It Matters
The funding signals growing momentum for radiology AI adoption and deployment at scale. CARPL.ai's global AI marketplace could accelerate clinical integration and broaden access to high-quality diagnostics, especially in emerging markets.
Source
Radiology Business
Related News
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.